Nova Eye Medical (AU:EYE) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nova Eye Medical Limited reported a significant increase in revenues up by 37% to $A 23,325 for the fiscal year ended 30 June 2024, but also a notable decrease in losses, with a 48% reduction in net loss before tax to $A 8,790. Despite the increased revenues, the company did not declare any dividends for the period and reported a slight decrease in net tangible asset backing per security from 4.4 cents to 4.3 cents.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
